Nav: Home

Large global range of prices for hepatitis C medicines raises concerns about affordability

May 31, 2016

The prices and affordability of recently developed and highly effective direct-acting antivirals for treating hepatitis C (HCV) vary greatly among countries worldwide, according to a study published this week in PLOS Medicine. Suzanne Hill and colleagues from the World Health Organization undertook an economic analysis of prices for a 12-week course of treatment with sofosbuvir and ledipasvir/sofosbuvir in 30 countries - mostly European as well as Egypt and Mongolia, adjusting for average 2015 exchange rates and purchasing power parity (PPP). While the nominal price based on exchange rates was highest in the US (US$72,765 for a 12-week course of ledipasvir/sofosbuvir), PPP-adjusted prices in Central and Eastern European countries were highest, costing up to 1.63 times as much in Poland (PPP$118,754 for a 12 week course of ledipasvir/sofosbuvir). The researchers went on to calculate the cost of treating the entire HCV infected population in each of the countries studied. Using previous estimates of HCV burden by country, they calculated that it would range from 10.5% of the total pharmaceutical expenditure (TPE) to treat all HCV patients in the Netherlands with the new HCV medications, to 190.5% of the TPE to treat all patients in Poland.

The authors note that their analysis is limited by the accuracy of the estimates of the numbers of people infected and price information that was accessible, and that some actual prices may be lower than the publicly accessible numbers because of confidential discounts. They also note, however, that they only considered the cost of sofosbuvir and ledipasvir/sofosbuvir and did not consider extra costs of treatment such as screening and follow-up. The authors say their analysis illustrates the wide range of affordability worldwide and suggests a need for an updated pricing system: "In order for countries to increase investment and minimise the burden of hepatitis C, governments and industry stakeholders will need to jointly develop and implement fairer pricing frameworks that deliver lower and more affordable prices".

In an accompanying Perspective, Elliot Marseille and James G. Kahn discuss the pricing of these new HCV medications in relation to the high initial cost when HIV anti-retroviral therapy was introduced in the 1990s. Marseille and Kahn compare and contrast the situations, and suggest ways forward such as treating a proportion of cases initially, to spread the upfront cost of HCV treatment over several years while fighting for lower drug prices.
-end-
Research Article

Funding:

The authors received no specific funding for this work.

Competing Interests:

SH is a member of the PLOS Medicine Editorial Board. KTT has been an employee of Deloitte Australia within the past 5 years. Deloitte Australia has provided consulting services to pharmaceutical companies. However, KTT has not been involved in any project directly related to the content of this manuscript that can lead to conflict of interest.

Citation:

Iyengar S, Tay-Teo K, Vogler S, Beyer P, Wiktor S, de Joncheere K, et al. (2016) Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis. PLoS Med 13(5): e1002032. doi:10.1371/journal.pmed.1002032

Author Affiliations:

World Health Organization, Geneva, Switzerland

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Health Economics Department, Gesundheit Österreich, Vienna, Austria

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002032

Perspective Article

Funding:

There was no funding for this work.

Competing Interests:

The authors have declared that no competing interests exist.

Citation:

Marseille E, Kahn JG (2016) A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact. PLoS Med 13(5): e1002031. doi:10.1371/journal.pmed.1002031

Author Affiliations:

Health Strategies International, Oakland, California, United States of America

Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California, United States of America

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1002031

PLOS

Related Hepatitis Articles:

Hepatitis C increasing among pregnant women
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.
WHO's Global Hepatitis Report sets baseline to eliminate viral hepatitis by 2030
The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO), which includes new data on the prevalence and global burden of viral hepatitis.
Elimination of viral hepatitis by 2030: What's needed and how do we get there?
This first European Action Plan provides an important driver to aid countries in their fight against viral hepatitis, to which ECDC had the opportunity to contribute directly.
Discovery of new Hepatitis C virus mechanism
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus with the potential of improving pathological liver conditions.
Is Europe ready to eliminate viral hepatitis?
Currently, Europe records around 57,000 newly diagnosed acute and chronic cases of hepatitis B and C each year.
Why baby boomers need a hepatitis C screening
Hepatitis C affects a disproportionate amount of older Americans, born between 1945 and 1965.
Counterattack of the hepatitis B virus
The hepatitis B virus (HBV) infects liver cells. Drugs are available to treat HBV, but they rarely cure the infection, and so the virus typically returns after the treatment ends.
Hepatitis C tied to increased risk of Parkinson's
The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the Dec.
The hepatitis A virus is of animal origin
The hepatitis A virus can trigger acute liver inflammation which generally has a mild course in small children but which can become dangerous in adults.
Modeling the helicase to understand hepatitis C
NS3 is an enzyme specific to the hepatitis C virus.

Related Hepatitis Reading:

NOFX: The Hepatitis Bathtub and Other Stories
by NOFX (Author), Jeff Alulis (Author)

NOFX: The Hepatitis Bathtub and Other Stories is the first tell-all autobiography from one of the world's most influential and controversial punk bands. Fans and non-fans alike will be shocked by the stories of murder, suicide, addiction, counterfeiting, riots, bondage, terminal illness, the Yakuza, and drinking pee. Told from the perspective of each of the band's members, this book looks back at more than thirty years of comedy, tragedy, and completely inexplicable success.
View Details


Hepatitis C Survival Secrets: With Critical Insights Your Doctor Won't Share
by Ralph Napolitano (Author)

Hepatitis C Survival Secrets can be of tremendous help to anyone with chronic Hepatitis C. The book is based on decades of ongoing research, including countless communications with other Hepatitis C survivors. The goal of the book is to present you with various treatment options that show real evidence for supporting, protecting and improving liver health and function.

As a Hepatitis C survivor you need to learn about the many strategies and approaches available to manage your illness. Some people choose to take the conventional medical approach simply because it's covered... View Details


HEPATITIS: A-to-E, Autoimmune, & Drug-induced: Symptoms, Transmissions, Diagnosis, Treatments, Diet, Preventions, Research
by James Lee Anderson (Author)

“Although, your health condition may impact your everyday life, do not let it define who you are.” Most people have heard of hepatitis, but few understand the harm posed by this potentially deadly collection of diseases. This text covers what you need to know about the disease. Inside, you’ll be able to know: (1) between acute and chronic hepatitis, (2) the different types of hepatitis, from A to E, (3) symptoms, causes and transmissions, diagnosis, treatments, and preventions, (4) about drug-induced hepatitis, (5) about autoimmune hepatitis, (6) how liver biopsy is done, (7)... View Details


Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease: A Practical Guide to Understanding, Treating & Living with Hepatitis & Liver
by Melissa Palmer (Author)

In the United States alone, more than four million people are infected with the hepatitis C virus, and chronic liver disease is the twelfth leading cause of death. In this revised and updated edition of her groundbreaking 2000 book, renowned hepatologist Dr. Melissa Palmer discusses all facets of liver disease, from symptoms and tests to treatment options and lifestyle changes. In addition, this comprehensive handbook reveals cutting-edge research on the dangers of hepatitis C, one of the world's fasting-growing microbial threats. View Details


Hepatitis C A Do-It-Yourself Guide for Health
by Lloyd Wright (Author), David Drum (Editor)

Hepatitis C: A Do-It-Yourself Guide for Health is the newest information I have compiled over the last 17 years. I have listed the supplements I have seen work best in over 200.000 hepatitis c suffers. I have cited numerous studies that show what works and what does not. I have listed the common drugs and vaccines that raise the viral load, ast and alt. You will learn what foods to eat, which are the best supplements for you to take and how to take them. Ansers to your frequently asked questions, blood tests you will need. How to treat the common complications of hepatitis C, Fibrosis,... View Details


Hepatitis C: A Complete Guide for Patients and Families (A Johns Hopkins Press Health Book)
by Paul J. Thuluvath (Author)

The liver is the body’s workhorse. It makes proteins and bile, processes fats, and detoxifies drugs and alcohol. The liver is a resilient organ, but it is susceptible to damage from a number of sources, including viral infections. Such infections cause inflammation of the liver, called hepatitis. This book is a comprehensive guide to hepatitis C, which affects about 3 percent of the world’s population―3 to 4 million people in the United States alone. Some people with acute hepatitis C infection will be cured without any treatment, but when hepatitis C becomes chronic it may cause... View Details


Hepatitis B Treatment: An Essential Self-Help Guide for Treating and Curing Hepatitis B (Hep B)
by Kandice Holverson (Author)

Hepatitis B is an infectious disease caused by a virus that attacks the DNA of your body's cells. It can occur without symptoms in some individuals until the infection becomes life threatening. For this reason, early detection and early action are crucial so as to prevent further complications and begin treatment measures. However, finding a cure for Hepatitis B virus can be a challenging task because people respond differently to medication. Since there is no single treatment for the condition and viruses are difficult to destroy, it is important to get a proper diagnosis from your doctor... View Details


A Never Event: Exposing the Largest Outbreak of Hepatitis C in American Healthcare History
by Evelyn V. McKnight (Author), Travis T. Bennington (Author)

CANCER CLINIC CAUSES WORST HEPATITIS OUTBREAK IN US HISTORY

In the small farming community of Fremont, Nebraska, townspeople eagerly welcomed an acclaimed doctor as the first full-time oncologist at their new cancer treatment center—but the fanfare soon turned into a nightmare.
During chemotherapy treatments, 857 patients who were already waging the fights of their lives against cancer, were inexplicably exposed to the deadly, blood-borne hepatitis C virus. At least ninety-nine of them contracted the lethal illness. The horror was unprecedented—this was the largest... View Details


Healing Hepatitis and Liver Disease Naturally: Detoxification. Liver gall bladder flush & Cleanse. Cure Hepatitis C and Hepatitis B. Lower blood cholesterol and stop cirrhosis
by Peter Oyakhire (Author)

LIVE YOUR LIFE EXPECTANCY WITH CHRONIC LIVER DISEASE.

Studies show that all wellness traditions except western medicine offer detoxification and toxic waste management as a means of natural healing. Using the principles of natural healing and detoxification, Dr. Alexis Carrel, a Nobel Prize winner kept chicken heart alive for 38 years. He believed that cells could live indefinitely and that the secret of life is to feed nutrients to cells and to saturate the cells with Oxygen. If you can't get nutrients into the cells and you don't remove the toxins, the cells will be poisoned by... View Details


The First Year---Hepatitis B: An Essential Guide for the Newly Diagnosed
by William Finley Green (Author), Hari Conjeevaram (Foreword)

The hepatitis B virus causes an estimated one million deaths each year worldwide, and despite the availability of a hepatitis B vaccine, a combined lack of awareness and educational resources has turned this virus into a deadly epidemic. Author William Finley Green, who has lived with hepatitis B for almost twenty-five years and has become an expert on the condition, guides those newly diagnosed step-by-step through the first year following diagnosis. He provides charts and tables, crucial information about the nature of the disease, treatment options, diet, exercise, social concerns, the... View Details

Best Science Podcasts 2017

We have hand picked the best science podcasts for 2017. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Simple Solutions
Sometimes, the best solutions to complex problems are simple. But simple doesn't always mean easy. This hour, TED speakers describe the innovation and hard work that goes into achieving simplicity. Guests include designer Mileha Soneji, chef Sam Kass, sleep researcher Wendy Troxel, public health advocate Myriam Sidibe, and engineer Amos Winter.
Now Playing: Science for the People

#448 Pavlov (Rebroadcast)
This week, we're learning about the life and work of a groundbreaking physiologist whose work on learning and instinct is familiar worldwide, and almost universally misunderstood. We'll spend the hour with Daniel Todes, Ph.D, Professor of History of Medicine at The Johns Hopkins University, discussing his book "Ivan Pavlov: A Russian Life in Science."